Home / People / AtaiStudy results of psilocybin treatment in bipolar II depression published in JAMA Psychiatry |...AtaiThu, Dec 7Congratulations to @COMPASSPathway on their latest publication in @JAMAPsych, detailing the results of COMP360, psilocybin treatment, in bipolar type II depression. These early efficacy signals for such a hard-to-treat indication are encouraging. https://t.co/gHexMRaKSI281910Believed to be first ever psilocybin clinical trial for treatment of bipolar II depressionRead More Discover AtaiNewsCannabisPsychedelicsAddictionDispensaryHealthOpioidsScience